Access cutting-edge community-acquired pneumonia treatment through this clinical trial at a research site in Sacramento. Study-provided care at no cost to qualified participants.
Access community-acquired pneumonia specialists in Sacramento at no cost
This study follows strict safety protocols and ethical guidelines
All study-related community-acquired pneumonia treatment provided free
The main objective of the trial is to assess the efficacy and safety of trimodulin as adjunctive treatment to standard of care (SoC) compared to placebo plus SoC in adult hospitalized subjects with sCAP on invasive mechanical ventilation (IMV). Other objectives are to determine detailed pharmacokinetic (PK) properties of trimodulin in a PK substudy and to determine its pharmacodynamic (PD) properties.
Sponsor: Biotest
Check if you qualify for this community-acquired pneumonia clinical trial in Sacramento, CA
If you're searching for community-acquired pneumonia treatment options in Sacramento, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Sacramento research site is actively enrolling participants for this clinical trial. You'll receive care from experienced community-acquired pneumonia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.